Cholesterol-lowering drugs may have a new use?reducing cancer, especially cancer of the kidney and prostate, according to the results of a Dutch study. The study, which looked at drug-dispensing records and hospital discharge records from 8 Dutch cities, found that statin use was connected with a 20% reduction in cancer risk.The researchers compared the use of statin drugs among 3219 patients with cancer and 16, 976 without cancer. All the participants were receiving at least 1 medication for cardiovascular disease.
Lead investigator Matthijs Graaf, PharmD, of the Academic Medical Center at the University of Amsterdam in the Netherlands, said, "People who used statins for less than 4 years did not have a significant risk reduction." The risk of cancer was 36% lower, however, in participants who took statins for at least 4 years, compared with that in people who did not take the drugs. Graaf stressed that more studies are needed before physicians advise patients to take statins solely as a means for decreasing the risk of cancer.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs